Wild-type (senile) amyloidosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Race) |
||
| Line 10: | Line 10: | ||
* The [[incidence]] of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.<ref name="pmid116772762">{{cite journal |vauthors=Khan MF, Falk RH |title=Amyloidosis |journal=Postgrad Med J |volume=77 |issue=913 |pages=686–93 |date=November 2001 |pmid=11677276 |pmc=1742163 |doi= |url=}}</ref> | * The [[incidence]] of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.<ref name="pmid116772762">{{cite journal |vauthors=Khan MF, Falk RH |title=Amyloidosis |journal=Postgrad Med J |volume=77 |issue=913 |pages=686–93 |date=November 2001 |pmid=11677276 |pmc=1742163 |doi= |url=}}</ref> | ||
* The actual incidence of wild-type (senile) amyloidosis in particular is unknown. | * The actual [[incidence]] of wild-type (senile) amyloidosis in particular is unknown. | ||
=== Prevalence === | === Prevalence === | ||
| Line 26: | Line 26: | ||
=== Race === | === Race === | ||
* There is no racial predilection to | * There is no racial predilection to wild-type (senile) amyloidosis. | ||
=== Gender === | |||
* Men are traditionally more affected by wild-type (senile) amyloidosis than women. | |||
==References== | ==References== | ||
Revision as of 17:57, 17 December 2019
|
Wild-type (senile) amyloidosis Microchapters |
|
Differentiating Wild-type (senile) amyloidosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wild-type (senile) amyloidosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis epidemiology and demographics |
|
FDA on Wild-type (senile) amyloidosis epidemiology and demographics |
|
CDC on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Wild-type (senile) amyloidosis epidemiology and demographics in the news |
|
Blogs on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Risk calculators and risk factors for Wild-type (senile) amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Incidence
- The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.[1]
- The actual incidence of wild-type (senile) amyloidosis in particular is unknown.
Prevalence
- The prevalence of wild-type (senile) amyloidosis has not been determined.
Mortality rate
- The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries.[2]
Age
- Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older).
Race
- There is no racial predilection to wild-type (senile) amyloidosis.
Gender
- Men are traditionally more affected by wild-type (senile) amyloidosis than women.